PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F15DE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $62,102
Award facts
- Contract value 100% obligated
- $62,101.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $62,101.83 by the Defense Logistics Agency's Medical Supply Chain on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price, non-set-aside contract represents a task order issued under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, Amerisourcebergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
This delivery order exemplifies the company's ongoing role in fulfilling federal medical supply requirements through open competition. Amerisourcebergen Drug Corp's extensive portfolio of federal contract awards with the DLA and its Medical Supply Chain demonstrates the contractor's capability to meet government procurement standards consistently. The contract structure, utilizing firm fixed pricing and a short performance window, reflects the operational efficiency required for medical supply delivery to Defense Health Agency systems, the U.S. Coast Guard, and other federal healthcare entities. The parent company, Cencora, Inc., maintains a parallel $999,999,999.00 IDC with the DLA through December 2031, underscoring the strategic importance of this vendor relationship in the federal pharmaceutical and medical supply chain.
Quick answers
Who was awarded contract SPE2D826F15DE?
SPE2D826F15DE was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 23, 2026.
How much is contract SPE2D826F15DE worth?
The government has obligated $62,102 on SPE2D826F15DE.
Is contract SPE2D826F15DE an order under another contract?
Yes. SPE2D826F15DE is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D826F15DE competed?
The extent of competition for SPE2D826F15DE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award